1Hussein AM. Chemotherapy-induced alopecia: new developments.South Med J, 1993, 86:489 -496.
2Hidalgo M, Rinaldi D, Medina G,et al. A phase 1 trial of topieal topitrinl ( ealcitriol, 1 , 25 - dihydroxyvitamin D3 ) to prevent chemotherapy-induced alopeeia. Antieaneer Drugs, 1999, 10:393 -395.
3Hussein AM, Jimenez JJ, McCall CA, et al. Protection from chemotherapy-induced alopecia in a rat model. Science, 1990, 249 : 1564 -1566.
4Paus R, Handjiski B, Eichmuller S, et al. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporinc A, and modulation bv dexamethasone. Am J Pathol, 1994,144:719 - 734.
5Slominski A, Paus R, Plonka P, et al. Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a naodel for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. J Invest Dennatol, 1996, 106:1203 - 1211.
6Lindner G, Botchkarev VA, Botehkareva NV, et al. Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol, 1997,151:1601 - 1617.
7Tobin DJ, Hagen E, Botehkarev VA, et al. Do hair bulb melanoeytes undergo apoptosis during hair follicle regression (catagen) ? J Invest Dermatol, 1998, 111:941 - 947.
8Muller-Rover S, Rossiter H, Paus R, et al. Overexpression of Bcl - 2protects from ultraviolet B-induced apoptosis but promotes hair follicle regression and chemotherapy-induced alopecia. Am J Pathol, 2000,156 : 1395 - 1405.
9Davis ST, Benson BG, Bramson HN, et al. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science, 2001, 291 :134 - 137.
10Lakin ND, Jackson SP, Regulation of p53 in response to DNA damage. Oncogcne, 1999, 18:7644 -7655.
